That FDA is studying gluten contamination in "gluten-free" foods is an indication that FDA plans to monitor this claim closely.
It appears that celiacs have good reason to be wary of processed foods that are not specifically labeled gluten-free. In an FDA study on over 400 market-sold foods, researchers found that even when products were presumably gluten-free-that is, their ingredient lists did not include wheat, rye, and barley-many of them were, in fact, contaminated with gluten.
Of 461 products that FDA purchased for its analysis, 98.9% of products with gluten-free labels did meet the legal definition of “gluten-free”-they contained less than 20 ppm of gluten. But 19.4% of products without the label surpassed the 20-ppm threshold, even though they didn’t list any gluten-containing ingredients. And about half of these offenders contained more than 100 ppm of gluten.
Depending on the circumstances of a manufacturer’s operations, foods not containing gluten may still come into contact with gluten from shared surfaces, gluten particles in the air, and other causes. For these circumstances, manufacturers can package their products with warning labels, such as “manufactured in a facility that also uses wheat” or “made on equipment shared with wheat.” In FDA’s study, half of the foods contaminated with gluten at levels above 20 ppm failed to include warning labels, so there’s wonder as to whether their manufacturers were unaware of the contamination threat or just didn’t want to use of warning labels.
Interestingly enough, breakfast cereals were the most likely culprits for gluten contamination in FDA’s study. Many of these cereals contained oats, which, despite not containing gluten by nature, are often at risk of contamination.
FDA’s analysis is published in the journal Food Chemistry.
Robby Gardner
Associate Editor
Nutritional Outlook magazine
robby.gardner@ubm.com
Photo © iStockphoto.com/dem10
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
September 19th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.